CATS Tonometer, LLC: Company Profile

Background

Overview

CATS Tonometer, LLC, established in 2013 and headquartered in Tucson, Arizona, specializes in the development of advanced tonometry solutions aimed at enhancing the accuracy of intraocular pressure (IOP) measurements. Their flagship product, the CATS Tonometer Prism™, is designed to improve the detection and management of ocular diseases, particularly glaucoma.

Mission and Vision

The company's mission is to revolutionize IOP measurement by providing clinicians with tools that deliver precise and reliable data, thereby facilitating timely and accurate diagnoses. Their vision is to establish the CATS Tonometer Prism™ as the new standard of care in IOP measurement, significantly improving patient outcomes in ocular health.

Primary Area of Focus

CATS Tonometer, LLC focuses on the ophthalmic medical device industry, specifically targeting the enhancement of tonometry practices to address the challenges associated with traditional IOP measurement methods.

Industry Significance

Glaucoma remains a leading cause of preventable blindness worldwide, affecting millions of individuals. Accurate IOP measurement is crucial for the early detection and management of this condition. By introducing the CATS Tonometer Prism™, the company aims to address longstanding inaccuracies in IOP assessments, thereby contributing to improved clinical practices and patient care.

Key Strategic Focus

Core Objectives

• Enhancing Diagnostic Precision: Developing and providing tonometry solutions that offer superior accuracy in IOP measurement.

• Seamless Integration: Ensuring that their products can be easily incorporated into existing clinical workflows without necessitating additional training or significant changes to current practices.

• Global Expansion: Expanding the availability of their products to a broader international market to address global needs in ocular health diagnostics.

Specific Areas of Specialization

• Tonometry Devices: Specializing in the design and manufacture of tonometer prisms that enhance the accuracy of IOP measurements.

• Ophthalmic Diagnostics: Focusing on developing tools that improve the detection and management of ocular diseases, particularly glaucoma.

Key Technologies Utilized

• Concave-Convex Surface Design: The CATS Tonometer Prism™ features a patented dual-curved surface that better conforms to the cornea, reducing measurement errors associated with traditional flat prisms.

• Ergonomic Design: The device is engineered for ease of use, allowing clinicians to integrate it into their practice without additional training.

Primary Markets Targeted

• Ophthalmology Clinics: Providing tools for specialists focused on eye health and diseases.

• Optometry Practices: Offering solutions for eye care professionals involved in vision correction and eye health assessments.

• Global Healthcare Systems: Addressing the needs of healthcare providers worldwide, particularly in regions with high incidences of glaucoma.

Financials and Funding

Funding History

CATS Tonometer, LLC has secured funding through various channels to support its research, development, and commercialization efforts. Notably, the company received a $1.1 million grant from the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) program, which has been instrumental in advancing their product development.

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly disclosed.

Notable Investors

While individual investors are not publicly listed, the NIH grant highlights the confidence in the company's potential and the importance of their innovation in the medical device sector.

Intended Utilization of Capital

The capital raised has been allocated towards:

• Product Development: Enhancing the design and functionality of the CATS Tonometer Prism™.

• Regulatory Approvals: Securing necessary certifications and clearances to market the product.

• Market Expansion: Increasing distribution capabilities and entering new markets.

Pipeline Development

Key Pipeline Candidates

• CATS Tonometer Prism™: The primary product, available in both reusable and disposable versions, designed to improve IOP measurement accuracy.

Stages of Clinical Trials or Product Development

• FDA Clearance: The CATS Tonometer Prism™ received FDA clearance in March 2018, marking a significant milestone in its development.

Target Conditions

• Glaucoma: Aiming to enhance the early detection and management of this leading cause of preventable blindness.

Relevant Timelines for Anticipated Milestones

• Product Availability: The CATS Tonometer Prism™ was introduced at the American Academy of Ophthalmology’s Annual Meeting in October 2019.

Technological Platform and Innovation

Proprietary Technologies

• Dual-Curved Surface Design: The CATS Tonometer Prism™ utilizes a unique concave-convex surface to improve IOP measurement accuracy.

Significant Scientific Methods

• Biomechanical Compensation: The device accounts for corneal biomechanics, including central corneal thickness, corneal hysteresis, tear film, and corneal curvature, to provide more accurate IOP readings.

Leadership Team

Sean McCafferty, M.D., FACS, MS – Chief Executive Officer

Dr. McCafferty holds an undergraduate degree in mechanical engineering from Youngstown State University, a Master of Science in optical engineering from the University of Arizona, and a medical degree from Ohio State University. He is a practicing ophthalmologist and has founded successful enterprises, including Arizona Eye Consultants and Camp Lowell Surgery Center. Dr. McCafferty has 10 patents and published patent applications focused on ophthalmic opto-mechanics.

Nannon Roosa, PMP, CPA, CMPE – President

Ms. Roosa brings 25 years of experience in client service, project management, strategic planning, intellectual property, and business development. She has previously worked with PricewaterhouseCoopers, KPMG, and Clifton Gunderson. Prior to joining CATS Tonometer, she served as the University of Arizona’s director for MBA Experiential Learning, leading 97 successful projects for clients in the technology and healthcare sectors.

Competitor Profile

Market Insights and Dynamics

The global tonometry market is evolving, with a growing emphasis on accuracy and patient safety. Traditional Goldmann Applanation Tonometry (GAT) has been the standard for decades, but its limitations have led to the development of alternative solutions like the CATS Tonometer Prism™.

Competitor Analysis

• Reichert Technologies: A leading manufacturer of tonometry devices, Reichert has expanded its portfolio to include the CATS Tonometer Prism™, enhancing its offerings in the IOP measurement segment.

• Nidek Co., Ltd.: A Japanese company with a significant presence in the tonometry market, holding multiple patents related to applanation tonometers.

Strategic Collaborations and Partnerships

• Reichert Technologies: Entered into an exclusive agreement to distribute the CATS Reusable Tonometer Prism in the United States, expanding market reach.

• Lovell Government Services: Partnered to distribute the CATS-D Disposable Tonometer Prism to federal healthcare systems, including the Department of Veterans Affairs and the Department of Defense.

Operational Insights

Strategic Considerations

CATS Tonometer, LLC's focus on innovation and strategic partnerships positions it to address the limitations of traditional tonometry methods. By offering both reusable and disposable versions of their product, they cater to diverse clinical preferences and needs.

Competitive Advantages

• Innovative Design: The dual-curved surface design of the CATS Tonometer Prism™ offers superior accuracy compared to traditional flat prisms.

• Seamless Integration: The device is designed for easy incorporation into existing clinical workflows without additional training.

Strategic Opportunities and Future Directions

Strategic Roadmap

• Product Diversification: Exploring additional ophthalmic diagnostic tools to complement the CATS Tonometer Prism™.

• Global Expansion: Increasing international distribution to address global needs in ocular health diagnostics.

Future Business Directions

CATS Tonometer, LLC aims to solidify its position as a leader in ophthalmic diagnostics by continually innovating and expanding its product offerings to meet the evolving needs of eye care professionals worldwide.